CONMED Corporation provided earnings guidance for the full year 2022. For the year 2022, the company expects full-year 2022 revenue in the range of $1.075 billion to $1.125 billion.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
66.98 USD | -0.69% | -0.33% | -38.86% |
17/06 | Conmed Insider Sold Shares Worth $287,280, According to a Recent SEC Filing | MT |
22/05 | CONMED Keeps Quarterly Dividend at $0.20 a Share, Payable July 5 to Shareholders of Record June 14 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.86% | 2.08B | |
-4.93% | 182B | |
-3.99% | 103B | |
-5.55% | 66.94B | |
+9.36% | 46.73B | |
-8.12% | 45.14B | |
+5.82% | 41.57B | |
+17.37% | 30.48B | |
+14.00% | 24.26B | |
-5.92% | 23.58B |
- Stock Market
- Equities
- CNMD Stock
- News CONMED Corporation
- CONMED Corporation Provides Earnings Guidance for the Full Year 2022